The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery

被引:89
作者
Kim, Ji-Eon [1 ]
Kountakis, Stilianos E. [1 ]
机构
[1] Med Coll Georgia, Dept Otolaryngol Head & Neck Surg, Augusta, GA 30912 USA
关键词
D O I
10.1177/014556130708600715
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
We conducted a retrospective study to determine the prevalence of Samter's triad (nasal polyps, asthma, and aspirin sensitivity) in 208 consecutively presenting patients who had undergone functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis from September 2001 through August 2003. Overall, Samter's triad was found in 10 patients (4.8%); subgroup analyses showed that the prevalence of Samter's triad was 5.9% in adults, 9.4% in patients with nasal polyps alone, 16.9% in patients with asthma alone, and 25.6% among patients with both polyps and asthma. On average, patients with Samter's triad had undergone approximately 10 times as many previous FESS procedures as had the patients without Samter's triad (mean: 5.2 vs. 0.53; p < 0.001). In addition to Samter's triad, four other factors were independently and significantly associated with a higher number of previous FESS procedures: nasal polyps alone, asthma alone, both polyps and asthma, and cystic fibrosis alone. Finally, at 6 months following their most recent surgery, patients with Samter's triad had significantly higher rates of symptom recurrence (nasal obstruction, facial pain, postnasal drip, and anosmia) and a recurrence of nasal polyps.
引用
收藏
页码:396 / 399
页数:4
相关论文
共 19 条
  • [1] Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma
    Antczak, A
    Montuschi, P
    Kharitonov, S
    Gorski, P
    Barnes, PJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (03) : 301 - 306
  • [2] Improvement of asprinin-intolerant asthma by montelukast, a leukotriene antagonist -: A randomized, double-blink, placebo-controlled trial
    Dahlén, SE
    Malmström, K
    Nizankowska, E
    Dahlén, B
    Kuna, P
    Kowalski, M
    Lumry, WR
    Picado, C
    Stevenson, DD
    Bousquet, J
    Pauwels, R
    Holgate, ST
    Shahane, A
    Zhang, J
    Reiss, TF
    Szczeklik, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (01) : 9 - 14
  • [3] RELEASE OF LEUKOTRIENES, PROSTAGLANDINS, AND HISTAMINE INTO NASAL SECRETIONS OF ASPIRIN-SENSITIVE ASTHMATICS DURING REACTION TO ASPIRIN
    FERRERI, NR
    HOWLAND, WC
    STEVENSON, DD
    SPIEGELBERG, HL
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (04): : 847 - 854
  • [4] Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib
    Gyllfors, P
    Bochenek, G
    Overholt, J
    Drupka, D
    Kumlin, M
    Sheller, J
    Nizankowska, E
    Isakson, PC
    Mejza, F
    Lefkowith, JB
    Dahlén, SE
    Szczeklik, A
    Murray, JJ
    Dahlén, B
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (05) : 1116 - 1121
  • [5] Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study
    Hedman, J
    Kaprio, J
    Poussa, T
    Nieminen, MM
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1999, 28 (04) : 717 - 722
  • [6] Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice
    Jenkins, C
    Costello, J
    Hodge, L
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7437): : 434 - 437
  • [7] KNAPP HR, 1992, J LAB CLIN MED, V119, P48
  • [8] Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma
    Martín-García, C
    Hinojosa, M
    Berges, P
    Camacho, E
    García-Rodriguez, R
    Alfaya, T
    Iscar, A
    [J]. CHEST, 2002, 121 (06) : 1812 - 1817
  • [9] Michel O, 1984, Rev Pneumol Clin, V40, P369
  • [10] NASAL POLYPS, NASAL POLYPECTOMY, ASTHMA, AND ASPIRIN SENSITIVITY - THEIR ASSOCIATION IN 445 CASES OF NASAL POLYPS
    MOLONEY, JR
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1977, 91 (10) : 837 - 846